Meeting
2021 ASCO Annual Meeting
Genome-wide association study to reveal novel germline markers of melanoma survival.
Authors
Vylyny Chat
New York University Medical Center, Manhattan, NY
Vylyny Chat , Robert Ferguson , Leah Morales , Una Moran , Min Jae Kim , Matija Snuderl , Iman Osman , Jeffrey S. Weber , Tomas Kirchhoff
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9581)
DOI
10.1200/JCO.2021.39.15_suppl.9581
Abstract #
9581
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Genetic variants involved in the lipid metabolism pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC trials.
First Author: Jingyuan Wang
Poster
2018 ASCO Annual Meeting
Genome-wide association with survival in stage II-III colon cancer clinical trials (NCCTG N0147, Alliance for Clinical Trials in Oncology; NSABP C-08, NRG Oncology).
First Author: Kathryn Penney
Poster
2015 ASCO Annual Meeting
XPC, XPF, TP53 and GSTP1 polymorphisms in prognosis of cutaneous melanoma patients.
First Author: Carmen Silvia Passos Lima
Poster
2013 ASCO Annual Meeting
Long-term survival in patients with metastatic melanoma who received ipilimumab in four phase II trials.
First Author: Celeste Lebbé